Online citations, reference lists, and bibliographies.

Role Of Transplant In Biliary Disease.

Margaret M Romine, Jared A. White
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Orthotopic liver transplantation (OLT) has many roles in biliary disease. OLT provides excellent results for patients with unresectable hilar cholangiocarcinoma. OLT prolongs survival in primary biliary cirrhosis not responsive to therapy and improves quality of life. OLT remains the durable option for patients with primary sclerosing cholangitis and complications of end-stage liver disease or recurrent cholangitis secondary to biliary obstruction. Indications for OLT after bile duct injury are chronic liver disease secondary to biliary cirrhosis and acute liver failure from associated vascular injury. OLT is treatment of choice for Caroli disease and syndrome when fibrosis leads to portal hypertension and esophageal varices.
This paper references
10.1111/J.1432-2277.2006.00292.X
The place of liver transplantation in Caroli's disease and syndrome.
Laurent De Kerckhove (2006)
10.1097/00007890-199811270-00006
Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?
D. Jeyarajah (1998)
10.1016/j.jpedsurg.2008.10.069
Congenital biliary atresia: liver injury begins at birth.
E. Makin (2009)
10.1016/j.jhep.2011.10.025
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.
K. Boonstra (2012)
10.1159/000077991
A Review and Update on Cholangiocarcinoma
M. Olnes (2004)
10.1016/j.cgh.2012.09.009
Classification, diagnosis, and management of cholangiocarcinoma.
Nataliya Razumilava (2013)
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS.
T. E. Starzl (1963)
10.1002/LT.20509
Orthotopic liver transplantation for biliary atresia: the U.S. experience.
N. Barshes (2005)
10.1097/00000658-199308000-00003
Open Cholecystectomy A Contemporary Analysis of 42,474 Patients
J. Roslyn (1993)
10.1002/ajmg.a.31926
Risk factors for isolated biliary atresia, National Birth Defects Prevention Study, 1997–2002
Natalie S The (2007)
10.1111/j.1440-1746.2007.04901.x
Liver histology in benign biliary stricture: fibrosis to cirrhosis . . . and reversal?
S. Sikora (2008)
10.1097/00000658-199705000-00004
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
J. Goss (1997)
10.1016/S0002-9610(98)00141-X
Colon carcinoma in patients undergoing liver transplantation.
R. Fabia (1998)
10.1007/s00268-007-9001-y
Surgical Resection of Hilar Cholangiocarcinoma: Analysis of Survival and Postoperative Complications
Suguru Hasegawa (2007)
10.4065/70.5.425
"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention.
D. Farley (1995)
10.1002/LT.20511
Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.
Jennifer Guy (2005)
Congenital choledochal cyst, with a report of 2, and an analysis of 94, cases.
F. Alonso-Lej (1959)
10.1016/0016-5085(94)90021-3
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
K. Lindor (1994)
10.1001/ARCHSURG.139.3.299
Factors predicting advanced hepatic fibrosis in patients with postcholecystectomy bile duct strictures.
S. Negi (2004)
10.1056/NEJM200102083440604
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.
P. Hammel (2001)
10.1067/MSY.2000.108422
Long-term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy.
S. Johnson (2000)
10.1002/LT.20123
Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.
J. Neuberger (2004)
10.1136/gut.20.2.137
Serum bilirubin: a prognostic factor in primary biliary cirrhosis.
J. Shapiro (1979)
Biliary atresia splenic malformation syndrome: an etiologic and prognostic subgroup.
M. Davenport (1993)
10.1002/LT.20719
Caroli's disease and orthotopic liver transplantation.
S. Habib (2006)
10.1053/JLTS.2003.50213
Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history.
P. Sylvestre (2003)
10.1002/lt.24955
Current status of liver transplantation for cholangiocarcinoma
N. Goldaracena (2018)
10.1002/LT.20266
Transplantation for hilar cholangiocarcinoma.
J. Heimbach (2004)
10.1016/J.JPEDS.2005.12.054
A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.
B. Shneider (2006)
10.1080/13651820701883114
Complex bile duct injuries: management.
Eduardo de Santibáñes (2008)
10.1002/hep.1840190512
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
E. J. Heathcote (1994)
10.1002/hep.22178
Mortality attributable to cholestatic liver disease in the United States.
Flavia D. Mendes (2008)
10.1016/S0168-8278(98)80283-3
Diverse morphology of biliary atresia in an animal model.
C. Petersen (1998)
10.1002/HEP.510300501
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
I. Graziadei (1999)
10.1097/01.TP.0000090867.83666.F7
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation
E. Sanchez (2003)
10.1056/NEJM199105303242204
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
R. Poupon (1991)
10.1111/j.1572-0241.2004.04067.x
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
K. Burak (2004)
10.1111/j.1399-0012.2005.00471.x
Long‐term follow‐up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients
D. Jacob (2006)
10.1055/S-2004-828896
Liver transplantation for unresectable perihilar cholangiocarcinoma.
J. Heimbach (2004)
10.1002/LT.21366
Caroli's disease and outcomes after liver transplantation.
F. Millwala (2008)
10.1016/S0168-8278(99)80097-X
Familial primary biliary cirrhosis reassessed: a geographically-based population study.
D. Jones (1999)
10.1097/01.TP.0000062570.83203.A3
Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients1
H. Vo Thi Diem (2003)
10.1016/j.jviscsurg.2014.05.006
Long-term consequences of bile duct injury after cholecystectomy.
Louise Barbier (2014)
10.1093/infdis/174.1.8
Detection of group C rotavirus in infants with extrahepatic biliary atresia.
M. Riepenhoff-talty (1996)
10.1016/j.jpedsurg.2008.04.012
Timing of liver transplantation in biliary atresia-results in 71 children managed by a multidisciplinary team.
R. Cowles (2008)
10.1016/S0002-9270(99)00602-4
Time course of histological progression in primary sclerosing cholangitis.
P. Angulo (1999)
10.1016/j.jpedsurg.2007.12.058
Cystic biliary atresia: an etiologic and prognostic subgroup.
E. Caponcelli (2008)
10.1055/s-0032-1329899
Clues to the etiology of bile duct injury in biliary atresia.
C. Mack (2012)
10.1016/S0140-6736(04)16045-5
Seamless management of biliary atresia in England and Wales (1999–2002)
M. Davenport (2004)
10.1002/lt.21260
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
E. Cholongitas (2008)
10.1542/peds.99.3.376
Epidemiology of biliary atresia: a population-based study.
P. Yoon (1997)
10.1002/LT.20965
Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.
G. Gores (2006)
10.1097/01.TP.0000058744.34965.38
Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis
A. Vera (2003)
10.1034/j.1600-6143.2002.20812.x
Radiochemotherapy and Transplantation Allow Long‐Term Survival For Nonresectable Hilar Cholangiocarcinoma
D. Sudan (2002)
10.1016/j.clinre.2011.02.007
Liver transplantation in PBC and PSC: indications and disease recurrence.
M. Carbone (2011)
10.1002/lt.500020203
The safety of continuous hepatic inflow occlusion during major liver resection.
D. Quan (1996)
10.1136/adc.2009.159780
Epidemiology of biliary atresia in England and Wales (1999–2006)
E Livesey (2009)
10.1002/lt.21679
A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
E. Alabraba (2009)
10.1016/J.TRANSPROCEED.2005.03.130
Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
D. Jacob (2005)
10.1007/978-3-319-22273-8_34
Liver Transplantation for Common Bile Duct Injury
Kelly Collins (2015)
Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients1:
H. Vo Thi Diem (2003)
10.1053/GAST.2000.20197
Epidemiology and natural history of primary biliary cirrhosis in a U.S. community
W. Kim (2000)
10.1093/annonc/mdu092
Adjuvant chemotherapy for bladder cancer-why does level 1 evidence not support it?
D. Raghavan (2014)
10.1093/annonc/mdv279
Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.
B. Groot Koerkamp (2015)
10.1016/0270-9139(95)90294-5
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
B. Combes (1993)
An analysis of the problem of biliary injury during laparoscopic cholecystectomy.
S. Strasberg (1995)
10.1002/LT.20358
Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center.
V. Fouquet (2005)
10.1016/S0140-6736(02)11861-7
Risk factors for recurrence of primary sclerosing cholangitis of liver allograft
A. Vera (2002)
10.1111/j.1432-2277.2007.00628.x
The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.
I. Rowe (2008)
10.1002/LT.21107
Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
H. T. J. Mantel (2007)
10.1097/00007890-200004270-00019
Liver transplantation for cholangiocarcinoma: results in 207 patients.
C. Meyer (2000)
10.1002/bjs.9349
Liver transplantation for bile duct injury after open and laparoscopic cholecystectomy
P. Parrilla (2014)
10.1200/JCO.1997.15.3.947
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.
J. Klempnauer (1997)
Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis.
C. Garcia (2004)
10.1016/J.GIE.2007.07.018
EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma.
F. Gleeson (2008)
10.1007/s00268-001-0106-4
Long-term Biliary Complications after Liver Surgery Leading to Liver Transplantation
C. Loinaz (2001)
10.1097/SLA.0000000000002574
Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease
Cecilia G Ethun (2018)
10.1007/s00431-008-0774-2
Incidence of hepatotropic viruses in biliary atresia
Stefan Rauschenfels (2008)
10.1007/s11605-010-1256-1
Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database
R. Kashyap (2010)



Semantic Scholar Logo Some data provided by SemanticScholar